Factory Direct Antiviral Powder Ganciclovir CAS 82410-32-0 Gvc with Best Quality

• Powder: Yes
• Customized: Customized
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: White Powder
• Purity: >99%
• Model NO.: Frazer-Ganciclovir
• Appearance: White Powder
• CAS No: 82410-32-0
• Shelf Life: 2 Years
• Test Method: HPLC
• MOQ: 1kg
• Storage: Store Cool Dry Place
• Resource: Natural
• Quality Requirement: Strictly Quality Control
• Market: Worldwide
• Service: Welcome to Visit Us
• Delivery Time: 7-10days
• Melting Point: 250°c
• MW: 255.23
• Transport Package: Foil Bag
• Specification: 99%
• Trademark: Xi′an Frazer Biotech Co., Ltd.
• Origin: China
• Production Capacity: 2500kg/Month

Product Description

Factory Direct Antiviral Powder Ganciclovir CAS 82410-32-0 Gvc with Best Quality

Specification of Analysis

Test	Specification	Result
Appearance	white powder	white powder
Solubility	Very slightly soluble in water	Complies
dentification	Ultraviolet absorption	Complies
	Infrared absorption	Complies
Water	≤6.0%	1.0%
Heavy metals	≤20ppm	<10ppm
Residue on ignition	≤0.1%	0.04%
Related impurities	Nomorethan0.5% compound A	0.08%
	No more than 1.5% for total impurities	0.50%
HPLC assay	98.0%~102.0%	99.5%

Description:

Ganciclovir is a parenterally-active antiviral agent indicated for sight- or life-threatening cytomegalovirus (CMV) infections in immunocompromised patients. Its suppressive effects on bone marrow and renal tubular secretion/absorption are reported to present potential limitations on adjunct therapies involving zidovudine, vincristine, adriamycin and amphotericin B. Recently, the emergence of CMV strains resistant to ganciclovir therapy has been reported.

Application:

1) Sight-threatening CMV retinitis in severely immunocompromised people
2) CMV pneumonitis in bone marrow transplant recipients
3) Prevention of CMV disease in bone marrow and solid organ transplant recipients
4) Confirmed CMV retinitis in people with AIDS (intravitreal implant)
5) It is also used for acute CMV colitis in HIV/AIDS and CMV pneumonitis in immunosuppressed patients